AbbVie Declares Quarterly Dividend

Rhea-AI Summary

AbbVie (NYSE: ABBV) declared a quarterly cash dividend of $1.73 per share, payable May 15, 2026, to holders of record at the close of business on April 15, 2026.

Since 2013 AbbVie has increased its dividend by more than 330% and remains a member of the S&P Dividend Aristocrats Index.

Positive

• Quarterly dividend set at $1.73 per share
• Dividend payable on May 15, 2026 to record holders as of April 15, 2026
• Dividend increased by over 330% since 2013
• Member of the S&P Dividend Aristocrats Index

Negative

• None.

News Market Reaction – ABBV

-1.91%

1 alert

-1.91% News Effect

On the day this news was published, ABBV declined 1.91%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

NORTH CHICAGO, Ill., Feb. 19, 2026 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.73 per share. 

The cash dividend is payable May 15, 2026, to stockholders of record at the close of business on April 15, 2026.

Since the company's inception in 2013, AbbVie has increased its dividend by more than 330 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.

Media: Gabby Tarbert (224) 244-0111 gabrielle.tarbert@abbvie.com

Investors: Liz Shea (847) 935-2211 liz.shea@abbvie.com

View original content:https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-302692715.html

SOURCE AbbVie

FAQ

What dividend did AbbVie (ABBV) declare on February 19, 2026?

AbbVie declared a $1.73 per share quarterly cash dividend. According to the company, the dividend is payable May 15, 2026 to stockholders of record on April 15, 2026.

When is the AbbVie (ABBV) dividend payment date and record date for the February 2026 declaration?

The dividend payment date is May 15, 2026 and the record date is April 15, 2026. According to the company, shareholders on the books at close of business April 15 will receive the May 15 payment.

How much has AbbVie (ABBV) increased its dividend since 2013?

AbbVie has increased its dividend by more than 330% since 2013. According to the company, this cumulative increase reflects its multi-year trend of raising payouts to shareholders.

Does AbbVie (ABBV) qualify as a Dividend Aristocrat after the February 2026 declaration?

Yes, AbbVie remains a member of the S&P Dividend Aristocrats Index. According to the company, the index tracks firms that have increased dividends for at least 25 consecutive years.

How will AbbVie's (ABBV) $1.73 dividend affect shareholders who buy shares after April 15, 2026?

Shareholders who purchase ABBV after April 15, 2026 will not be eligible for the May 15 dividend. According to the company, only holders of record at close of business April 15 receive the payment.

Is the $1.73 dividend from AbbVie (ABBV) a one-time payment or part of regular payouts?

The $1.73 payment is a quarterly cash dividend, consistent with AbbVie's regular payout schedule. According to the company, this continues its multi-year pattern of periodic dividend increases.